当前位置: X-MOL 学术Clin. Gastroenterol. Hepatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cost-Benefit Analysis of Hydrogen Breath Test–Directed Rifaximin for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Clinical Gastroenterology and Hepatology ( IF 11.6 ) Pub Date : 2022-09-22 , DOI: 10.1016/j.cgh.2022.09.010
Alicia Muratore 1 , Eric D Shah 2 , Walter W Chan 3
Affiliation  

Abstract not available

中文翻译:

氢气呼气试验指导的利福昔明治疗腹泻型肠易激综合征的成本效益分析

摘要不可用
更新日期:2022-09-22
down
wechat
bug